Jabil’s Third Quarter of Fiscal Year 2022 Earnings Announcement Set
Get Alerts JBL Hot Sheet
Overall Analyst Rating:
BUY ( Down)
Dividend Yield: 0.3%
Revenue Growth %: -21.8%
Join SI Premium – FREE
ST. PETERSBURG, Fla.--(BUSINESS WIRE)-- Today, Jabil Inc. (NYSE: JBL), a manufacturing solutions company, announced it will release its third quarter of fiscal year 2022 financials on Thursday, June 16, 2022, before the market opens.
The company will host a conference call and webcast to review the results on Thursday, June 16, 2022, at 8:30 a.m. ET.
What: Jabil’s Third Quarter of Fiscal Year 2022 Conference Call and Webcast
When: Thursday, June 16, 2022 – 8:30 a.m. ET
Dial-in: U.S. (877) 407-6184 or International (201) 389-0877
To access the live audio webcast and the accompanying slide presentation, visit the Investor Relations section of Jabil’s website, located at https://investors.jabil.com. An archived replay of the webcast will be available after completion of the call.
About Jabil: Jabil (NYSE: JBL) is a manufacturing solutions provider with over 260,000 employees across 100 locations in 30 countries. The world's leading brands rely on Jabil's unmatched breadth and depth of end-market experience, technical and design capabilities, manufacturing know-how, supply chain insights and global product management expertise. Driven by a common purpose, Jabil and its people are committed to making a positive impact on their local community and the environment. Visit www.jabil.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005754/en/
Investor Contact:
Adam Berry
Vice President, Investor Relations
[email protected]
Source: Jabil, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- UPL CORP ANNOUNCES COMPLETION OF ACQUISITION OF CORTEVA'S SOLO MANCOZEB BUSINESS
- AAVantgarde presents positive preclinical data in large animal models from its Stargardt disease program in an oral presentation at the ASGCT 2024 annual meeting
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!